Skip to content

Clinical trials

Observational Lymphoma, Non-Hodgkin trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Observational Clear all

207 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20033
20046
20058
20067
200711
200820
20099
201010
20117
20124
20131
20144
20155
20168
201711
20187
20192
20208
20218
20229
202317
20246
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed101
Recruiting35
Unknown status20
Terminated19
Withdrawn10
Not yet recruiting9
Active, not recruiting8
Enrolling by invitation5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Memorial Sloan Kettering Cancer Center8
Mayo Clinic6
City of Hope Medical Center5
Ruijin Hospital5
Stanford University5
Vanderbilt-Ingram Cancer Center5
Wake Forest University Health Sciences5
Hoffmann-La Roche4
SWOG Cancer Research Network4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin207
Hodgkin Disease75
Lymphoma58
Lymphoma, Large B-Cell, Diffuse58
Leukemia, Lymphocytic, Chronic, B-Cell53
Precursor Cell Lymphoblastic Leukemia-Lymphoma51
Lymphoma, Follicular49
Multiple Myeloma47
Leukemia40
Lymphoma, B-Cell, Marginal Zone39

Trials

Showing 1 to 25 of 207. Each trial links to its page on Pharma Observatory.

107 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.